Stock Report

Download full stock data and analysis for free Last Updated: 02-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Celyad Oncology SA - ADR Key Ratios

Stock Card factsheet share-fund-plan-icon

$0.52

up-down-arrow $-0.03 (-5.42%)

As on 20-Jul-2023 09:30EDT

Market cap

info icon

$14 Mln

Revenue (TTM)

info icon

$-- Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.7

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT -- 545.88 -54.81 -15.24 4.96
Net Profit -- 529.10 -54.40 -17.07 4.96
EPS -- -- -- -- --
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-22Dec-21Dec-20
EBIT-Margin info -524,780.00-338,509.84-----524,780.00
Net Margin info ---239,200.75------
Return on equity info -95.82-83.32-170.72-71.05-45.69
Return on Capital info -89.31-78.36-161.03-65.54-41.37
Return on Assets info -46.97-43.11-82.15-36.31-22.45
Debt to Equity (x) info ----0.060.060.12

Profitability

View Detailed Peer Comparison

ROCE

-161.03

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Celyad Oncology SA - ADR
-161.03
-65.54
-41.37
-53.41
-70.47
Peer Median
--
--
--
--
--
ROE

-170.72

--

Profit after tax / Average Net worth * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Celyad Oncology SA - ADR
-170.72
-71.05
-45.69
-56.58
-72.58
Peer Median
--
--
--
--
--
ROA

-82.15

--

Profit after tax / Average Total assets * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Celyad Oncology SA - ADR
-82.15
-36.31
-22.45
-31.10
-43.54
Peer Median
--
--
--
--
--
EBIT Margin

--

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Celyad Oncology SA - ADR
--
--
-524,780.00
-489,550.00
-1,199.52
Peer Median
--
--
--
--
--
Net Margin

--

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Celyad Oncology SA - ADR
--
--
-350,020.00
-477,200.00
-1,201.51
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

--

--

Year on year growth in net sales

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Celyad Oncology SA - ADR
--
-1.00
-0.17
-1.00
-0.12
Peer Median
--
--
--
--
--
EBIT Growth

-54.81

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Celyad Oncology SA - ADR
-54.81
-0.58
10.67
21.39
33.62
Peer Median
--
--
--
--
--
Net Profit Growth

-54.40

--

Year on year growth in profit after tax

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Celyad Oncology SA - ADR
-54.40
-51.49
38.88
23.50
33.63
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.06

--

Total debt / Net worth

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Celyad Oncology SA - ADR
0.06
0.06
0.12
0.10
0.03
Peer Median
--
--
--
--
--
Short term debt to equity ratio

0.03

--

(Short term borrowings / Net worth)

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Celyad Oncology SA - ADR
0.03
0.02
0.04
0.03
0.01
Peer Median
--
--
--
--
--
Current Ratio

1.42

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Celyad Oncology SA - ADR
1.42
2.48
1.67
3.59
5.36
Peer Median
--
--
--
--
--
Quick Ratio

--

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Celyad Oncology SA - ADR
--
--
1.53
3.59
5.36
Peer Median
--
--
--
--
--
Interest Coverage

-207.40

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Celyad Oncology SA - ADR
-207.40
-103.49
-88.35
-85.64
-602.66
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Celyad Oncology SA - ADR
--
--
18,140.00
45,033.33
40.74
Peer Median
--
--
--
--
--
Asset Turnover

--

--

Sales / Average Total Assets

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Celyad Oncology SA - ADR
--
--
0.00
0.00
0.04
Peer Median
--
--
--
--
--
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Celyad Oncology SA - ADR
--
--
131,818.73
120,867.31
167.73
Peer Median
--
--
--
--
--
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Celyad Oncology SA - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Celyad Oncology SA - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Celyad Oncology SA - ADR
--
--
--
--
--
Peer Median
--
--
--
--
--
loading...
loading...